Zepbound vs Ozempic
Different molecules, different makers. Zepbound is tirzepatide; Ozempic is semaglutide.
Zepbound and Ozempic are often compared because both are weekly GLP-1 injections — but they are not the same medication. Zepbound (Eli Lilly) contains tirzepatide, a dual GLP-1 / GIP agonist FDA-approved for weight management. Ozempic (Novo Nordisk) contains semaglutide, FDA-approved for type 2 diabetes.
Side by side.
Who picks which.
- Weight management is the goal
- Want the strongest weight-loss data and the dual mechanism
- Type 2 diabetes diagnosis
- Already responding well on semaglutide and stable
These are not interchangeable. Match the medication to your clinical reason: Zepbound for weight management, Ozempic for diabetes. For off-label weight management, the appropriate semaglutide brand is Wegovy.
See if I qualifyPrescription treatments require an online visit reviewed by a U.S.-licensed provider, who determines if a treatment is clinically appropriate. Compounded medications are prepared by licensed U.S. pharmacies and are not FDA-approved. Individual results vary.
Questions, answered.
Can I take both?
Which has fewer side effects?
Related comparisons
All comparesSame family, different math: GLP-1 alone or GLP-1 + GIP. Here is how to choose.
Read the comparison →Two FDA-approved brands, two different molecules. The choice is really semaglutide vs tirzepatide, with branded pricing.
Read the comparison →Same active ingredient (semaglutide). Different FDA label. Here is what that actually means.
Read the comparison →